Trials / Recruiting
RecruitingNCT06212921
Biomarkers in Prediction of AMI
Biomarkers In Prediction of Acute Mesenteric Ischaemia: a Prospective Multicentre Study (BIPAMI Study)
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 250 (estimated)
- Sponsor
- University of Tartu · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Current study will be undertaken to identify combinations of biomarkers that can reliably identify acute mesenteric ischaemia (AMI) and distinguish between non-transmural and transmural ischaemia. Different combinations of biomarkers for different sub-types and severity of AMI, and different time points of measurement after onset of symptoms.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Sequential blood samples | Sequential blood samples for diagnostic tests is the only intervention in thei study |
Timeline
- Start date
- 2024-10-14
- Primary completion
- 2025-09-01
- Completion
- 2025-12-01
- First posted
- 2024-01-19
- Last updated
- 2024-12-03
Locations
2 sites across 2 countries: Estonia, Switzerland
Source: ClinicalTrials.gov record NCT06212921. Inclusion in this directory is not an endorsement.